Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors

被引：75
|
作者：
Gellibert, F. [1 ]
Fouchet, M. -H. [1 ]
Nguyen, V. -L. [1 ]
Wang, R. [2 ]
Krysa, G. [1 ]
de Gouville, A. -C. [1 ]
Huet, S. [1 ]
Dodic, N. [1 ]
机构：
[1] GlaxoSmithKline Inc, F-91951 Les Ulis, France
[2] GlaxoSmithKline Inc, Res Triangle Pk, NC 27703 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 08期
关键词：
Transforming growth factor-beta; ALK5; P38MAP Kinase; Liver fibrosis; I RECEPTOR KINASE; TGF-BETA; FIBROSIS; CANCER;
D O I：
10.1016/j.bmcl.2009.02.087
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Starting from quinazoline 3a, we designed potent and selective ALK5 inhibitors over p38MAP kinase from a rational drug design approach based on co-crystal structures in the human ALK5 kinase domain. The quinazoline 3d exhibited also in vivo activity in an acute rat model of DMN-induced liver fibrosis when administered orally at 5 mg/kg (bid). (c) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2277 / 2281
页数：5
相关论文
共 50 条
  • [1] Design and synthesis of novel thiazole-derivatives as potent ALK5 inhibitors
    Arai, Mai
    Hanada, Mitsuharu
    Moriyama, Hideki
    Ohmoto, Hiroshi
    Miyake, Takahiro
    Naka, Kazuhito
    Sawa, Masaaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 108
  • [2] Synthesis of novel ALK5 inhibitors
    Hall, Thomas
    Kelsey, Lauren
    Streu, Craig
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [3] LINEAR RESPONSE APPROXIMATION (LRA) APPROACHES FOR CALCULATING BINDING AFFINITIES OF QUINAZOLINE ANALOGUES AS ALK5 INHIBITORS
    Alam, Md Afroz
    Davina, Thalitha Jane
    Devi, Anurupa
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (02): : 583 - 595
  • [4] THE QUINAZOLINE DERIVATIVES AS NOVEL POTENT AND SELECTIVE INHIBITORS OF CYCLIC GMP-PHOSPHODIESTERASE
    TAKASE, Y
    WATANABE, N
    MATSUI, M
    IKUTA, H
    SAEKI, T
    ADACHI, H
    SOUDA, S
    SAITO, I
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 227 - MEDI
  • [5] Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors
    Wang, Haixia
    Lawson, J. David
    Scorah, Nick
    Kamran, Ruhi
    Hixon, Mark S.
    Atienza, Joy
    Dougan, Douglas R.
    Sabat, Mark
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (17) : 4334 - 4339
  • [6] Design, Synthesis, and Activity of a Novel Series of Pyridazine-Based ALK5 Inhibitors
    Pala, Daniele
    Ronchi, Paolo
    Rescigno, Donatella
    Bertani, Barbara
    Capelli, Anna Maria
    Guariento, Sara
    Marchini, Gessica
    Milioli, Marco
    Cesari, Nicola
    Federico, Giuseppina
    Grandi, Andrea
    Stellari, Franco F.
    Fernandez, Sergio Xanxo
    Pappani, Alice
    Venturi, Luca
    Biagetti, Matteo
    Civelli, Maurizio
    Semeraro, Teresa
    Bianchi, Federica
    Trist, Iuni M. L.
    Remelli, Rosaria
    Armani, Elisabetta
    Pizzirani, Daniela
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (11): : 1925 - 1932
  • [7] Design, synthesis and biological evaluation of quinazoline derivatives as potent and selective FGFR4 inhibitors
    Pan, Chenghao
    Nie, Wenwen
    Wang, Jiao
    Du, Jiamin
    Pan, Zhichao
    Gao, Jian
    Lu, Yang
    Che, Jinxin
    Zhu, Hong
    Dai, Haibin
    Chen, Binhui
    He, Qiaojun
    Dong, Xiaowu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 225
  • [8] Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors
    Wang, YG
    Chackalamannil, S
    Hu, ZY
    Boyle, CD
    Lankin, CM
    Xia, Y
    Xu, R
    Asberom, T
    Pissarnitski, D
    Stamford, AW
    Greenlee, WJ
    Skell, J
    Kurowski, S
    Vemulapalli, S
    Palamanda, J
    Chintala, M
    Wu, P
    Myers, J
    Wang, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) : 3149 - 3152
  • [9] Design, synthesis, and pharmacological evaluation of quinazoline derivatives as novel and potent pan-JAK inhibitors
    Xiang, Jinbao
    Wang, Yuji
    Wang, Wanhe
    Yu, Jianxin
    Zheng, Lianyou
    Hong, Yuan
    Shi, Lingling
    Zhang, Chunling
    Chen, Na
    Xu, Jia
    Gong, Xuelian
    Zhang, Zhuoqi
    Cui, Hongming
    Zhou, Qian
    Zhang, Dapeng
    Liu, Yanjun
    Ke, Ying
    Shen, Jingkang
    Xia, Guangxin
    Bai, Xu
    BIOORGANIC CHEMISTRY, 2023, 140
  • [10] Optimization of quinazoline derivatives as selective MEK5 inhibitors
    Patel, Saloni
    Motta, Austin
    Flaherty, Patrick
    Bhatt, Akshita
    Wright, Thomas
    Cavanaugh, Jane
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
12345